Memantine induced dyskinesia in Alzheimer's disease

被引：0
作者：
Kaiserova, M.
Hvizdosova, L.
Mensikova, K.
Kanovsky, P.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
1458
引用
收藏
页码：S596 / S596
页数：1
相关论文
共 50 条
[31]   Are we prescribing memantine in Alzheimer's disease efficiently? [J].
Rasanayagam, C. ;
Schwartz-Mesa, J. .
EUROPEAN PSYCHIATRY, 2018, 48 :S182-S182
[32]   Memantine in Alzheimer's disease - results of an observational study [J].
Froelich, L. ;
Hartmann, S. ;
Lambert-Baumann, J. ;
Foerstl, H. .
EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 :347-347
[33]   Memantine - A Review of its Role in Alzheimer's Disease [J].
Kuo, Alexander .
CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2005, 58 :27-28
[34]   Discontinuing Donepezil or Starting Memantine for Alzheimer's Disease [J].
Schneider, Lon S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10) :957-959
[35]   Memantine - A review of its use in Alzheimer's disease [J].
Robinson, Dean M. ;
Keating, Gillian M. .
DRUGS, 2006, 66 (11) :1515-1534
[36]   Memantine (Namenda) for moderate to severe Alzheimer's disease [J].
Ables, AZ .
AMERICAN FAMILY PHYSICIAN, 2004, 69 (06) :1491-1492
[37]   Memantine Derivatives as Multitarget Agents in Alzheimer's Disease [J].
Marotta, Giambattista ;
Basagni, Filippo ;
Rosini, Michela ;
Minarini, Anna .
MOLECULES, 2020, 25 (17)
[38]   Effectiveness and Safety of Memantine Treatment for Alzheimer's Disease [J].
Yang, Zhendong ;
Zhou, Xiangyu ;
Zhang, Qi .
JOURNAL OF ALZHEIMERS DISEASE, 2013, 36 (03) :445-458
[39]   Preclinical basis for the efficacy of memantine in Alzheimer's disease [J].
Banerjee, P. K. ;
Lahiri, D. K. ;
Tanila, H. ;
Miguel-Hidalgo, J. J. ;
Iqbal, K. .
EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 :187-187
[40]   Memantine prodrug as a new agent for Alzheimer’s Disease [J].
Simona Sestito ;
Simona Daniele ;
Deborah Pietrobono ;
Valentina Citi ;
Lorenza Bellusci ;
Grazia Chiellini ;
Vincenzo Calderone ;
Claudia Martini ;
Simona Rapposelli .
Scientific Reports, 9
12345